Search - tctmd.com

Displaying 21 - 40 of 45

Sort: Relevancy | Date

Presentation TCT 2016

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Presenter: Marie-Claude Morice, Philip M. Urban

October 31, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

News Industry News

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

October 30, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

Presentation JIM 2016

BioFreedom DCS With 1-Month DAPT: The New Standard For High Bleeding Risk Patients

Presenter: Antonio L. Bartorelli

February 10, 2016

News Features

精益求精：创新支架技术值得继续探索

Todd Neale

November 08, 2015

News Features

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

Todd Neale

November 08, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

Presentation TCT 2015

BioFreedom II: LEADERS FREE Rationale and Late-Breaking Clinical Trial Preview

Presenter: Marie-Claude Morice, Leif Thuesen, Philip M. Urban

October 12, 2015

Presentation TCT 2015

BioFreedom I: Angiographic Results and Late Clinical Outcomes of the FIM Trial

Presenter: Marie-Claude Morice, Leif Thuesen, Christian M. Spaulding

October 12, 2015

News Industry News

Early Healing Profile Established for BioFreedom

May 20, 2015

Presentation TCT 2014

BioFreedom: From Pilot Results to the Leaders-Free Trial

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Philip M. Urban

September 15, 2014

News Industry News

Biosensors Announces IDE Approval for BioFreedom™ U.S. Trial

May 05, 2014

News Industry News

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

October 31, 2013

Presentation TCT 2013

Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial

Presenter: 208788|Ricardo Costa

October 29, 2013

News Conference News TCT 2013

Cre8, BioFreedom Polymer-Free DES Show Promise

October 28, 2013

Presentation TCT 2013

BioFreedom Stent and LEADERS FREE Trial

Presenter: Philip Urban

October 27, 2013

Advertisement

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

BioFreedom DCS With 1-Month DAPT: The New Standard For High Bleeding Risk Patients

精益求精：创新支架技术值得继续探索

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

BioFreedom II: LEADERS FREE Rationale and Late-Breaking Clinical Trial Preview

BioFreedom I: Angiographic Results and Late Clinical Outcomes of the FIM Trial

Early Healing Profile Established for BioFreedom

BioFreedom: From Pilot Results to the Leaders-Free Trial

Biosensors Announces IDE Approval for BioFreedom™ U.S. Trial

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial

Cre8, BioFreedom Polymer-Free DES Show Promise

BioFreedom Stent and LEADERS FREE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content